These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19846469)

  • 1. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.
    Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ
    Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
    Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
    Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide production by polymorphonuclear leucocytes in infected cystic fibrosis sputum consumes oxygen.
    Kolpen M; Bjarnsholt T; Moser C; Hansen CR; Rickelt LF; Kühl M; Hempel C; Pressler T; Høiby N; Jensen PØ
    Clin Exp Immunol; 2014 Jul; 177(1):310-9. PubMed ID: 24611476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia.
    Jensen PØ; Moser C; Kharazmi A; Presler T; Koch C; Høiby N
    J Cyst Fibros; 2006 Aug; 5(3):145-51. PubMed ID: 16503423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphonuclear Leukocytes or Hydrogen Peroxide Enhance Biofilm Development of Mucoid
    Tan Q; Ai Q; Xu Q; Li F; Yu J
    Mediators Inflamm; 2018; 2018():8151362. PubMed ID: 30116152
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
    Williams HD; Zlosnik JE; Ryall B
    Adv Microb Physiol; 2007; 52():1-71. PubMed ID: 17027370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
    Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
    Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
    Hansen CR; Pressler T; Koch C; Høiby N
    J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
    Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaerobic culture conditions favor biofilm-like phenotypes in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    O'May CY; Reid DW; Kirov SM
    FEMS Immunol Med Microbiol; 2006 Dec; 48(3):373-80. PubMed ID: 17052266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection.
    Kolpen M; Kühl M; Bjarnsholt T; Moser C; Hansen CR; Liengaard L; Kharazmi A; Pressler T; Høiby N; Jensen PØ
    PLoS One; 2014; 9(1):e84353. PubMed ID: 24465406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
    Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
    J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells.
    Friedl P; König B; König W
    Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.